Recent explosion at Zaporizhzhia nuclear power plant in Ukraine shows how pharma industry can pull together and take action in the face of adversity.
Bob Mulroy
Advertisement
Bob Mulroy is director and chief executive officer of Partner Therapeutics
Articles by Bob Mulroy
Advertisement
Latest Updated Articles
Partnering to Respond to a Possible Nuclear ThreatPublished: May 25th 2022 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Thermo Fisher Enters $8.8 Billion Definitive Agreement to Acquire Clario Holdings
2
Lilly Forms Partnership with NVIDIA to Create AI Supercomputer
3
Investors Have Questions About GLP-1 Drug Prices Ahead of Eli Lilly and Novo Quarterly Statements: Report
4
FDA Announces New Biosimilar-Targeted Draft Guidance
5
